Y70 Pill - yellow round, 8mm
Pill with imprint Y70 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Aurobindo Pharma Limited.
Rabeprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; Duodenal Ulcer Prophylaxis; Duodenal Ulcer; GERD and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Y70
Rabeprazole Sodium Delayed-Release
- Imprint
- Y70
- Strength
- 20 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0721
- Inactive Ingredients
-
diacetylated monoglycerides,
ethylcellulose (7 mPa.s),
ferric oxide yellow,
hypromellose phthalate (31% phthalate, 40 cst),
magnesium stearate,
mannitol,
magnesium oxide,
magnesium hydroxide,
sodium carbonate,
magnesium silicate,
titanium dioxide,
ferrosoferric oxide,
shellac
Note: Inactive ingredients may vary.
Related images for "Y70"
More about rabeprazole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (84)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: proton pump inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.